All In Biotech

Drug Trial Radar · NCT07832292

A Study of JNJ-101556143 in Participants With Metastatic Prostate Cancer

A Phase 2, Open-label, Multicenter, Single-arm Trial of JNJ-101556143, an Androgen Receptor-targeted Regulated Induced Proximity Targeting Chimera (RIPTAC™) Therapeutic in Participants With Metastatic Androgen Pathway Modulation-Resistant Prostate Cancer

Last checked: Nov 20, 2026Latest source record: Nov 3, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

Recruiting

Status

Recruiting

Enrollment

100

Planned (sponsor's estimate)

Start

Sep 16, 2026

Primary completion

May 17, 2029

Study completion May 20, 2030

Sponsor

Lead sponsor
Janssen Research & Development, LLCJohnson & Johnson (Janssen) (JNJ)
Sponsor type
Industry
First posted
Sep 21, 2026

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 2
Allocation
Not applicable (single group)
Model
Single group
Masking
None
Primary purpose
Treatment
FDA-regulated drug
Yes
Who can join
Male only, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The purpose of this study is to evaluate how well JNJ-101556143 works in participants with metastatic androgen pathway modulation-resistant prostate cancer (mAPMR), an advanced form of prostate cancer that has spread and no longer responds to hormone therapy. The study will measure the overall response (tumor shrinkage or disappearance) following treatment with JNJ-101556143.

Conditions

  • Prostatic Neoplasms

Interventions

  • JNJ-101556143Drug

    Participants will receive JNJ-101556143 orally.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Overall Response Rate (ORR)Time frame: Up to 2 years and 8 months

Locations

14 sites in 4 countries. Site status is shown where the registry gives one.

  • Advanced Urology Institute

    Largo, Florida · Recruiting

  • Associated Urological Specialists

    Chicago Ridge, Illinois · Recruiting

  • Urology of Indiana

    Carmel, Indiana · Recruiting

  • Southern Urology LLC

    Lafayette, Louisiana · Recruiting

  • Greater Boston Urology

    Plymouth, Massachusetts · Recruiting

  • Associated Medical Professionals

    Syracuse, New York · Recruiting

  • The Conrad Pearson Clinic

    Germantown, Tennessee · Recruiting

  • Icon Ctr Chermside

    Chermside, Australia · Recruiting

  • Epworth Healthcare

    East Melbourne, Australia · Recruiting

  • Icon Cancer Ctr Hobart

    Hobart, Australia · Recruiting

  • Icon Cancer Centre Kurralta Park

    Kurralta Park, Australia · Recruiting

  • Sun Yat Sen University Cancer Center

    Guangzhou, China · Recruiting

  • The First Affiliated Hospital of Wenzhou Medical University

    Wenzhou, China · Recruiting

  • Kobe University Hospital

    Kobe, Japan · Recruiting

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.